Virscio
Hamden
About Virscio
Virscio is a biotechnology company that develops therapeutics for central nervous system disorders such as neurodegeneration, memory loss, and obesity. The company utilizes PrimaTox, which is a predictive toxicogenomics platform that enables pharmaceutical candidate selection and pre-clinical validation. Virscio is based in Hamden, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2008)
- Website: virscio.com
- Phone: 2037762893
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/virscio-2434038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.